Sangamo Therapeutics, Inc. (SGMO)
USD 0.73
(-1.74%)
USD 0.73
(-1.74%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -274 Million USD | 43.22% |
| 2022 | -201.28 Million USD | -9.79% |
| 2021 | -183.33 Million USD | -41.52% |
| 2020 | -129.55 Million USD | -23.17% |
| 2019 | -105.18 Million USD | -36.33% |
| 2018 | -77.15 Million USD | -36.89% |
| 2017 | -56.36 Million USD | 22.32% |
| 2016 | -72.55 Million USD | -54.86% |
| 2015 | -46.85 Million USD | -74.96% |
| 2014 | -26.78 Million USD | -0.28% |
| 2013 | -26.7 Million USD | -20.31% |
| 2012 | -22.19 Million USD | 38.03% |
| 2011 | -35.82 Million USD | -43.66% |
| 2010 | -24.93 Million USD | -28.52% |
| 2009 | -19.4 Million USD | 23.54% |
| 2008 | -25.37 Million USD | -2.44% |
| 2007 | -24.77 Million USD | -19.5% |
| 2006 | -20.72 Million USD | -50.78% |
| 2005 | -13.74 Million USD | 6.16% |
| 2004 | -14.65 Million USD | -24.48% |
| 2003 | -11.76 Million USD | 62.72% |
| 2002 | -31.56 Million USD | -10.98% |
| 2001 | -28.44 Million USD | -127.84% |
| 2000 | -12.48 Million USD | -220.08% |
| 1999 | -3.9 Million USD | -12.78% |
| 1998 | -3.45 Million USD | -157.1% |
| 1997 | -1.34 Million USD | -322.96% |
| 1996 | -318 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -34.03 Million USD | 18.28% |
| 2024 Q1 | -45.37 Million USD | 27.24% |
| 2023 Q4 | -62.36 Million USD | 41.39% |
| 2023 Q1 | 135.17 Million USD | 344.04% |
| 2023 Q3 | -106.4 Million USD | 13.89% |
| 2023 Q2 | -123.57 Million USD | -191.42% |
| 2023 FY | -114.29 Million USD | 43.22% |
| 2022 Q4 | -55.39 Million USD | -0.91% |
| 2022 Q3 | -54.89 Million USD | -20.03% |
| 2022 FY | -201.28 Million USD | -9.79% |
| 2022 Q1 | -45.26 Million USD | -13.44% |
| 2022 Q2 | -45.73 Million USD | -1.05% |
| 2021 Q2 | -48.7 Million USD | -5.18% |
| 2021 Q1 | -46.3 Million USD | -6.61% |
| 2021 FY | -183.33 Million USD | -41.52% |
| 2021 Q3 | -48.43 Million USD | 0.54% |
| 2021 Q4 | -39.89 Million USD | 17.63% |
| 2020 Q3 | -3.7 Million USD | 90.23% |
| 2020 Q1 | -44.52 Million USD | -3130.77% |
| 2020 Q2 | -37.89 Million USD | 14.88% |
| 2020 Q4 | -43.43 Million USD | -1073.52% |
| 2020 FY | -129.55 Million USD | -23.17% |
| 2019 Q4 | 1.46 Million USD | 105.02% |
| 2019 Q2 | -33.5 Million USD | 23.68% |
| 2019 Q1 | -43.89 Million USD | -111.33% |
| 2019 FY | -105.18 Million USD | -36.33% |
| 2019 Q3 | -29.24 Million USD | 12.7% |
| 2018 Q4 | -20.77 Million USD | -27.9% |
| 2018 FY | -77.15 Million USD | -36.89% |
| 2018 Q1 | -20.99 Million USD | -52.53% |
| 2018 Q2 | -19.14 Million USD | 8.84% |
| 2018 Q3 | -16.24 Million USD | 15.15% |
| 2017 FY | -56.36 Million USD | 22.32% |
| 2017 Q3 | -13.03 Million USD | -2.09% |
| 2017 Q1 | -16.79 Million USD | -70.82% |
| 2017 Q2 | -12.76 Million USD | 23.96% |
| 2017 Q4 | -13.76 Million USD | -5.61% |
| 2016 FY | -72.55 Million USD | -54.86% |
| 2016 Q1 | -16.68 Million USD | -6.43% |
| 2016 Q2 | -26.84 Million USD | -60.91% |
| 2016 Q3 | -19.2 Million USD | 28.45% |
| 2016 Q4 | -9.83 Million USD | 48.82% |
| 2015 Q1 | -6.22 Million USD | -39.2% |
| 2015 Q2 | -12.27 Million USD | -97.35% |
| 2015 Q3 | -12.68 Million USD | -3.32% |
| 2015 Q4 | -15.67 Million USD | -23.56% |
| 2015 FY | -46.85 Million USD | -74.96% |
| 2014 Q1 | -7.61 Million USD | 6.89% |
| 2014 Q4 | -4.46 Million USD | 41.61% |
| 2014 Q3 | -7.65 Million USD | -8.61% |
| 2014 FY | -26.78 Million USD | -0.28% |
| 2014 Q2 | -7.04 Million USD | 7.41% |
| 2013 Q2 | -5.46 Million USD | 20.81% |
| 2013 Q1 | -6.9 Million USD | -104.96% |
| 2013 FY | -26.7 Million USD | -20.31% |
| 2013 Q4 | -8.17 Million USD | -32.72% |
| 2013 Q3 | -6.15 Million USD | -12.64% |
| 2012 Q3 | -5.8 Million USD | -1.01% |
| 2012 Q1 | -7.28 Million USD | -14.42% |
| 2012 FY | -22.19 Million USD | 38.03% |
| 2012 Q4 | -3.36 Million USD | 41.93% |
| 2012 Q2 | -5.74 Million USD | 21.13% |
| 2011 Q2 | -10.28 Million USD | -7.08% |
| 2011 FY | -35.82 Million USD | -43.66% |
| 2011 Q4 | -6.36 Million USD | 33.52% |
| 2011 Q1 | -9.6 Million USD | -15.15% |
| 2011 Q3 | -9.57 Million USD | 6.88% |
| 2010 FY | -24.93 Million USD | -28.52% |
| 2010 Q1 | -4 Million USD | -65.76% |
| 2010 Q2 | -3.87 Million USD | 3.1% |
| 2010 Q3 | -8.71 Million USD | -124.67% |
| 2010 Q4 | -8.33 Million USD | 4.33% |
| 2009 FY | -19.4 Million USD | 23.54% |
| 2009 Q2 | -5.15 Million USD | 26.58% |
| 2009 Q1 | -7.02 Million USD | -219.46% |
| 2009 Q4 | -2.41 Million USD | 49.73% |
| 2009 Q3 | -4.8 Million USD | 6.86% |
| 2008 Q2 | -7.98 Million USD | 9.3% |
| 2008 Q1 | -8.8 Million USD | -15.79% |
| 2008 Q4 | -2.19 Million USD | 65.54% |
| 2008 Q3 | -6.38 Million USD | 20.12% |
| 2008 FY | -25.37 Million USD | -2.44% |
| 2007 Q2 | -5.83 Million USD | 2.81% |
| 2007 FY | -24.77 Million USD | -19.5% |
| 2007 Q1 | -6 Million USD | 38.74% |
| 2007 Q4 | -7.6 Million USD | -43.02% |
| 2007 Q3 | -5.31 Million USD | 8.89% |
| 2006 FY | -20.72 Million USD | -50.78% |
| 2006 Q3 | -3.64 Million USD | 10.54% |
| 2006 Q2 | -4.07 Million USD | -26.93% |
| 2006 Q1 | -3.2 Million USD | -9.86% |
| 2006 Q4 | -9.8 Million USD | -169.17% |
| 2005 FY | -13.74 Million USD | 6.16% |
| 2005 Q2 | -3.45 Million USD | 3.46% |
| 2005 Q3 | -3.79 Million USD | -9.72% |
| 2005 Q4 | -2.92 Million USD | 23.0% |
| 2005 Q1 | -3.58 Million USD | -5.33% |
| 2004 FY | -14.65 Million USD | -24.48% |
| 2004 Q2 | 3.39 Million USD | 206.86% |
| 2004 Q1 | -3.17 Million USD | -56.68% |
| 2004 Q4 | -3.39 Million USD | 27.29% |
| 2004 Q3 | -4.67 Million USD | -237.62% |
| 2003 Q4 | -2.02 Million USD | 31.59% |
| 2003 Q2 | -3.7 Million USD | -20.58% |
| 2003 Q1 | -3.07 Million USD | -196.71% |
| 2003 FY | -11.76 Million USD | 62.72% |
| 2003 Q3 | -2.96 Million USD | 19.9% |
| 2002 Q3 | -21.6 Million USD | -443.17% |
| 2002 Q4 | -1.03 Million USD | 95.21% |
| 2002 Q1 | -4.95 Million USD | -24.58% |
| 2002 Q2 | -3.97 Million USD | 19.67% |
| 2002 FY | -31.56 Million USD | -10.98% |
| 2001 Q3 | -18.19 Million USD | -458.83% |
| 2001 Q1 | -3.02 Million USD | 22.05% |
| 2001 Q4 | -3.97 Million USD | 78.15% |
| 2001 FY | -28.44 Million USD | -127.84% |
| 2001 Q2 | -3.25 Million USD | -7.67% |
| 2000 Q2 | -2.71 Million USD | 2.73% |
| 2000 FY | -12.48 Million USD | -220.08% |
| 2000 Q3 | -3.1 Million USD | -14.49% |
| 2000 Q4 | -3.87 Million USD | -24.9% |
| 2000 Q1 | -2.78 Million USD | 0.0% |
| 1999 FY | -3.9 Million USD | -12.78% |
| 1998 FY | -3.45 Million USD | -157.1% |
| 1997 FY | -1.34 Million USD | -322.96% |
| 1996 FY | -318 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | -137.203% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -20.688% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 2.895% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -2657.243% |
| Apollomics, Inc. | -54.83 Million USD | -399.699% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1933.055% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -773.267% |
| Bicycle Therapeutics plc | -189.94 Million USD | -44.254% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -226.531% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -59.507% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -983.881% |
| Chimerix, Inc. | -93.06 Million USD | -194.423% |
| CRISPR Therapeutics AG | -222.53 Million USD | -23.127% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1804.329% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -271.976% |
| Fortress Biotech, Inc. | -142.34 Million USD | -92.498% |
| Fortress Biotech, Inc. | -142.34 Million USD | -92.498% |
| Gritstone bio, Inc. | -154.63 Million USD | -77.196% |
| Allakos Inc. | -196.05 Million USD | -39.759% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -400.046% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -125.528% |
| Cytokinetics, Incorporated | -496.2 Million USD | 44.78% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -951.439% |
| Innoviva, Inc. | 176.7 Million USD | 255.06% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -3462.095% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2220.687% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -115.647% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2124803.257% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -167.171% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -208.335% |
| ImmuCell Corporation | -5.74 Million USD | -4666.898% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -103.829% |
| Incyte Corporation | 620.52 Million USD | 144.157% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -102.626% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -4093.512% |
| Mustang Bio, Inc. | -50.72 Million USD | -440.167% |
| MiMedx Group, Inc. | 37.11 Million USD | 838.24% |
| MEI Pharma, Inc. | 14.54 Million USD | 1984.232% |
| MacroGenics, Inc. | -168.24 Million USD | -62.862% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -3002.68% |
| Mereo BioPharma Group plc | -28.41 Million USD | -864.263% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1779.143% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -108.393% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -765.789% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1085.164% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1624.821% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -2174.089% |
| NextCure, Inc. | -67.63 Million USD | -305.111% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -431.987% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -2494.007% |
| Onconetix, Inc. | -36.03 Million USD | -660.394% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -556.866% |
| Opthea Limited | -191.84 Million USD | -42.828% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -362.21% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -9857.21% |
| PDS Biotechnology Corporation | -43.04 Million USD | -536.551% |
| Precigen, Inc. | -88.92 Million USD | -208.137% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -820.839% |
| Prime Medicine, Inc. | -191.29 Million USD | -43.239% |
| PureTech Health plc | -146.19 Million USD | -87.419% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -5.525% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 106.77% |
| Replimune Group, Inc. | -234.77 Million USD | -16.711% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3065.249% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1237.197% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1311.05% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 43.758% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1027.286% |
| Sesen Bio, Inc. | -25.9 Million USD | -957.567% |
| Solid Biosciences Inc. | -104.31 Million USD | -162.671% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -19.156% |
| SciSparc Ltd. | -5.77 Million USD | -4646.319% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -206.912% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1427.994% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -131.462% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -3665.357% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 27.27% |
| UroGen Pharma Ltd. | -65.53 Million USD | -318.098% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -316.681% |
| XOMA Corporation | -41.84 Million USD | -554.762% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -10.047% |
| AbCellera Biologics Inc. | -237.2 Million USD | -15.513% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -382.752% |
| Cassava Sciences, Inc. | -105.95 Million USD | -158.6% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -507.856% |
| Precision BioSciences, Inc. | -43.73 Million USD | -526.498% |
| Dyadic International, Inc. | -8.22 Million USD | -3229.449% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -3193.725% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -22886.997% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -836.513% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -108.856% |
| IGM Biosciences, Inc. | -263.46 Million USD | -4.002% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -154.836% |
| Acelyrin, Inc. | -422.06 Million USD | 35.08% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -481.32% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 2394.465% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1263.902% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -250.368% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -112.427% |
| Senti Biosciences, Inc. | -92.72 Million USD | -195.496% |
| Mesoblast Limited | -58.79 Million USD | -366.042% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -65.532% |
| ChromaDex Corporation | -5.59 Million USD | -4793.82% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5618.605% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -492.366% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -3307.215% |
| Seer, Inc. | -103.46 Million USD | -164.834% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -522.597% |
| Novavax, Inc. | -566.51 Million USD | 51.633% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1646.391% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -43.826% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -425.437% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -11.611% |
| Celcuity Inc. | -66.23 Million USD | -313.715% |
| ContextLogic Inc. | -328 Million USD | 16.462% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -63.769% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -180.473% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 147.358% |
| Amarin Corporation plc | -67.58 Million USD | -305.405% |
| AnaptysBio, Inc. | -164.41 Million USD | -66.659% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -848.836% |
| Aptorum Group Limited | -10.52 Million USD | -2503.786% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -217.077% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -33.66% |
| Ardelyx, Inc. | -63.27 Million USD | -333.031% |
| Celularity Inc. | -192.28 Million USD | -42.498% |
| Omeros Corporation | -164.53 Million USD | -66.538% |
| Humacyte, Inc. | -100.04 Million USD | -173.876% |
| Immunocore Holdings plc | -59.64 Million USD | -359.362% |
| IO Biotech, Inc. | -91.44 Million USD | -199.646% |
| GT Biopharma, Inc. | -13.57 Million USD | -1918.304% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -267.004% |
| Summit Therapeutics Inc. | -89.73 Million USD | -205.346% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -699.618% |
| Pulmatrix, Inc. | -14.74 Million USD | -1758.921% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 46.825% |
| Evogene Ltd. | -26.39 Million USD | -938.252% |
| CorMedix Inc. | -48.95 Million USD | -459.676% |
| BioLineRx Ltd. | -49.69 Million USD | -451.384% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -729.79% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -791.363% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 21.579% |
| scPharmaceuticals Inc. | -55.39 Million USD | -394.63% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -147.601% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 355.406% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2220.687% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1027.286% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -58.503% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1176.46% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -965.836% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -138.736% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -229.916% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -415.761% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1349.939% |
| Daré Bioscience, Inc. | -30.83 Million USD | -788.476% |
| bluebird bio, Inc. | -244.26 Million USD | -12.177% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 240.919% |
| DBV Technologies S.A. | -76.43 Million USD | -258.495% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -16.302% |
| Galecto, Inc. | -39.9 Million USD | -586.643% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -639.275% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -427.004% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -24.99% |
| GlycoMimetics, Inc. | -39.27 Million USD | -597.652% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -13.647% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1366.665% |
| Clene Inc. | -40.54 Million USD | -575.888% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 21.726% |
| Aptose Biosciences Inc. | -52.35 Million USD | -423.35% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1800.071% |
| Soligenix, Inc. | -7.69 Million USD | -3459.459% |
| Century Therapeutics, Inc. | -146.54 Million USD | -86.975% |
| Kura Oncology, Inc. | -165.8 Million USD | -65.258% |
| Surrozen, Inc. | -45.78 Million USD | -498.526% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -193.185% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -10941.292% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -4125.864% |
| Autolus Therapeutics plc | -195.02 Million USD | -40.495% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -223.665% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1196.451% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -136.091% |
| GRI Bio, Inc. | -11.38 Million USD | -2306.297% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -5967.81% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -275.457% |
| INmune Bio, Inc. | -29.74 Million USD | -821.304% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -147.711% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -619.639% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1614.743% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -3227.75% |
| Jaguar Health, Inc. | -34.29 Million USD | -699.058% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1637.417% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -348.468% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1002.902% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 0.725% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -34.846% |
| Verastem, Inc. | -92.08 Million USD | -197.56% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -48.799% |
| Histogen Inc. | -10.64 Million USD | -2474.509% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1670.978% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -273.411% |
| Surrozen, Inc. | -45.78 Million USD | -498.526% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1716.287% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -5282.953% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -3489.816% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -59.972% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -465.566% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1700.204% |
| Kronos Bio, Inc. | -121.83 Million USD | -124.908% |
| Turnstone Biologics Corp. | -59.03 Million USD | -364.164% |
| Synaptogenix, Inc. | -8.31 Million USD | -3195.764% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1778.548% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -8565.56% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -198.835% |
| Exelixis, Inc. | 170.88 Million USD | 260.345% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -76.706% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 47.013% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -297.91% |
| ESSA Pharma Inc. | -32.13 Million USD | -752.692% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1500.211% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1366.993% |
| Insmed Incorporated | -709.62 Million USD | 61.387% |
| MediWound Ltd. | -15.29 Million USD | -1692.054% |
| OmniAb, Inc. | -69.41 Million USD | -294.712% |
| Alector, Inc. | -151.74 Million USD | -80.575% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -153.748% |
| Zai Lab Limited | -366.57 Million USD | 25.252% |
| AlloVir, Inc. | -181.33 Million USD | -51.108% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 13.502% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -147.342% |
| Aura Biosciences, Inc. | -84.99 Million USD | -222.393% |
| Immunic, Inc. | -99.22 Million USD | -176.151% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -91.4% |
| Veracyte, Inc. | -85.79 Million USD | -219.372% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 2.771% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1828.255% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 415.63% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -3878.036% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1358.046% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -976.514% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 806.162% |
| Fortrea Holdings Inc. | 63.1 Million USD | 534.239% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -95.098% |
| XBiotech Inc. | -37.51 Million USD | -630.485% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -297.91% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -61.235% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -623.56% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -308.232% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -153.929% |
| Agenus Inc. | -159.54 Million USD | -71.737% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -967.33% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -414.158% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 51.862% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -249.087% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -164.206% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1131.31% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -97.082% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -4775.419% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -976.26% |
| Lantern Pharma Inc. | -17.87 Million USD | -1432.675% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -537.221% |
| Ainos, Inc. | -13.2 Million USD | -1974.79% |
| Pluri Inc. | -22.15 Million USD | -1136.596% |
| Prothena Corporation plc | -191.03 Million USD | -43.431% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -98.5% |
| Rallybio Corporation | -78.93 Million USD | -247.141% |
| Kodiak Sciences Inc. | -277.32 Million USD | 1.196% |
| Cue Biopharma, Inc. | -52.14 Million USD | -425.427% |
| MeiraGTx Holdings plc | -137.06 Million USD | -99.915% |
| Annexon, Inc. | -143.72 Million USD | -90.648% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -323.855% |
| Moderna, Inc. | -4.23 Billion USD | 93.536% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1376.4% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1019.164% |
| Blueprint Medicines Corporation | -486.27 Million USD | 43.652% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1597.56% |
| CalciMedica, Inc. | -21.87 Million USD | -1152.594% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -91.196% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -59.961% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -302.972% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 16.181% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -666.555% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -305.627% |
| Nutriband Inc. | -4.87 Million USD | -5524.162% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -528.265% |
| Vor Biopharma Inc. | -126.03 Million USD | -117.402% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 106.459% |
| Alkermes plc | 414.12 Million USD | 166.165% |
| ProKidney Corp. | -151.52 Million USD | -80.835% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -324.584% |
| Arcellx, Inc. | -89.88 Million USD | -204.856% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 54.887% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -139.991% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -619.702% |
| Atai Life Sciences N.V. | -125.47 Million USD | -118.381% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -235.629% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -236.578% |
| MediciNova, Inc. | -9.9 Million USD | -2667.653% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -116.822% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3683.314% |
| GeoVax Labs, Inc. | -26.74 Million USD | -924.588% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -18.195% |
| Biomea Fusion, Inc. | -126.13 Million USD | -117.232% |
| RenovoRx, Inc. | -11.39 Million USD | -2304.396% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -43.391% |
| Geron Corporation | -193.94 Million USD | -41.28% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -893.24% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -142.768% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -13.149% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -987.494% |
| Royalty Pharma plc | 1.49 Billion USD | 118.363% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -31.737% |
| Imunon, Inc. | -21.03 Million USD | -1202.898% |
| BioAtla, Inc. | -129.68 Million USD | -111.282% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 16.395% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -556.174% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -60.277% |
| Structure Therapeutics Inc. | -102.77 Million USD | -166.607% |
| 89bio, Inc. | -151.2 Million USD | -81.215% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -160.369% |
| aTyr Pharma, Inc. | -54.91 Million USD | -398.926% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -213.41% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -7.685% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -3236.335% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1530.4% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3098442.016% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 181.169% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -59.537% |
| Liquidia Corporation | -73.38 Million USD | -273.385% |
| Entera Bio Ltd. | -8.89 Million USD | -2981.824% |
| GH Research PLC | -41.22 Million USD | -564.706% |
| Vericel Corporation | -6.46 Million USD | -4138.939% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -250.825% |
| Xencor, Inc. | -138.63 Million USD | -97.639% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -5215.755% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1614.743% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1174.968% |
| Vaxcyte, Inc. | -468.04 Million USD | 41.457% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -28.007% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1863.912% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -4093.512% |
| Portage Biotech Inc. | -18.25 Million USD | -1401.15% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3683.314% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -161.054% |
| OncoCyte Corporation | -25.13 Million USD | -990.09% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2323.781% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2291.582% |
| Purple Biotech Ltd. | 22.27 Million USD | 1330.322% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -839.757% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -835.011% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -48.627% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -3547.564% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -824.724% |
| United Therapeutics Corporation | 1.18 Billion USD | 123.125% |
| HilleVax, Inc. | -133.34 Million USD | -105.486% |
| Silo Pharma, Inc. | -3.85 Million USD | -7006.691% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -6850.829% |
| Pharming Group N.V. | -4.87 Million USD | -5515.381% |
| Tharimmune, Inc. | -9.45 Million USD | -2797.923% |
| Genprex, Inc. | -31.07 Million USD | -781.738% |
| Apogee Therapeutics, Inc. | -93 Million USD | -194.62% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -45.597% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -233.356% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -35717.647% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -4930.459% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1739644.11% |
| Savara Inc. | -60 Million USD | -356.622% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1462.261% |
| Curis, Inc. | -48.33 Million USD | -466.923% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -5151.875% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -905.523% |
| BeiGene, Ltd. | -1.2 Billion USD | 77.313% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -192.578% |
| Erasca, Inc. | -141.52 Million USD | -93.609% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -5952.719% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -5952.719% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -543.068% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -4208.255% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -307.521% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -77.301% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -31.651% |
| Adicet Bio, Inc. | -152.03 Million USD | -80.221% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -272.826% |
| Aditxt, Inc. | -26.06 Million USD | -951.341% |
| Adagene Inc. | -23.71 Million USD | -1055.171% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3648.308% |
| Quantum-Si incorporated | -111.17 Million USD | -146.472% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1779.609% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 324.568% |
| Compugen Ltd. | -12.99 Million USD | -2009.029% |
| Generation Bio Co. | -138.56 Million USD | -97.748% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -230.007% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -216.915% |
| Invivyd, Inc. | -207.78 Million USD | -31.871% |
| Relay Therapeutics, Inc. | -373 Million USD | 26.54% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -2821.628% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1375.569% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2563.605% |
| 2seventy bio, Inc. | -216.7 Million USD | -26.443% |
| Instil Bio, Inc. | -159.16 Million USD | -72.147% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1037.996% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -7367.965% |
| GeoVax Labs, Inc. | -26.74 Million USD | -924.588% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -645.957% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -164.223% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -60.916% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 59.959% |
| Evaxion Biotech A/S | -22.19 Million USD | -1134.424% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -232.603% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -22.804% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -242.742% |
| Cingulate Inc. | -22.75 Million USD | -1103.931% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 3757.301% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -513.439% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -341.417% |
| Clearmind Medicine Inc. | -8.74 Million USD | -3034.584% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -259.605% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -9242.189% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -171.758% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 27.987% |
| ImmunityBio, Inc. | -362.25 Million USD | 24.36% |
| Korro Bio, Inc. | -84.53 Million USD | -224.136% |
| Kineta, Inc. | -15.72 Million USD | -1642.702% |
| BioVie Inc. | -32.17 Million USD | -751.487% |
| Codexis, Inc. | -68.06 Million USD | -302.54% |
| Celularity Inc. | -192.28 Million USD | -42.498% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1583.491% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -23.089% |
| Virax Biolabs Group Limited | -6.49 Million USD | -4117.75% |
| Cibus, Inc. | -318.88 Million USD | 14.074% |
| IN8bio, Inc. | -30.33 Million USD | -803.204% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -121.345% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1068.764% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 22.538% |
| Eyenovia, Inc. | -25.4 Million USD | -978.486% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 939.476% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4826.375% |
| Elevation Oncology, Inc. | -45.44 Million USD | -502.938% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -246.259% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -503.376% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -99.702% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -780.79% |
| Moolec Science SA | -6.65 Million USD | -4018.02% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -348.175% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -533.494% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -66.911% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -444.06% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2837.489% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1151.469% |
| Humacyte, Inc. | -100.04 Million USD | -173.876% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -241.942% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1784.491% |
| Genelux Corporation | -24.16 Million USD | -1033.892% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -707.726% |
| Notable Labs, Ltd. | -14.65 Million USD | -1769.448% |
| Immunovant, Inc. | -282.7 Million USD | 3.079% |
| Quantum-Si incorporated | -111.17 Million USD | -146.472% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1188.405% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -168.601% |
| Acasti Pharma Inc. | -11.31 Million USD | -2322.251% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1095.427% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -562.104% |
| PepGen Inc. | -84.76 Million USD | -223.249% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1096.685% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -735.174% |
| Immuneering Corporation | -58.41 Million USD | -369.083% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -5282.953% |
| Belite Bio, Inc | -31.66 Million USD | -765.243% |
| XOMA Corporation | -41.84 Million USD | -554.762% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -305.813% |
| Bionomics Limited | -17.89 Billion USD | 98.469% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 867.951% |
| uniQure N.V. | -282.87 Million USD | 3.134% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3648.308% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -111.58% |
| Forte Biosciences, Inc. | -32.48 Million USD | -743.456% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -3197.786% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -832.148% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4826.375% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1828.255% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -2982.518% |
| Altimmune, Inc. | -95.92 Million USD | -185.633% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -274.785% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 867.951% |
| Peak Bio, Inc. | -1356.23 USD | -20203331.571% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -452.385% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1118.341% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -13.084% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -821.149% |
| Zura Bio Limited | -62.63 Million USD | -337.442% |
| PolyPid Ltd. | -22.86 Million USD | -1098.255% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -821.149% |
| argenx SE | -425.04 Million USD | 35.536% |
| Immunome, Inc. | -109.53 Million USD | -150.164% |
| Verona Pharma plc | -67.83 Million USD | -303.953% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -951.439% |
| Shattuck Labs, Inc. | -91.95 Million USD | -197.971% |
| CervoMed Inc. | -7.81 Million USD | -3407.087% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1956.94% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -468.782% |
| Moolec Science SA | -6.65 Million USD | -4018.02% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1565.842% |
| Design Therapeutics, Inc. | -78.19 Million USD | -250.435% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -214.8% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -576.572% |
| Achilles Therapeutics plc | -75.25 Million USD | -264.102% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -9242.189% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -394.157% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -438.998% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -314.537% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -406.263% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -503.416% |
| Beam Therapeutics Inc. | -176.48 Million USD | -55.257% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -151.026% |
| AEON Biopharma, Inc. | -48.42 Million USD | -465.787% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -280.917% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -228.036% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2076.907% |
| NeurAxis, Inc. | -6.66 Million USD | -4011.414% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 40.506% |
| Lumos Pharma, Inc. | -36.61 Million USD | -648.361% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 5413.973% |
| Palisade Bio, Inc. | -13.07 Million USD | -1996.442% |
| Nutriband Inc. | -4.87 Million USD | -5524.162% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -278.256% |
| Neurogene Inc. | -55.58 Million USD | -392.965% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3123.209% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -183.326% |
| Athira Pharma, Inc. | -125.46 Million USD | -118.39% |
| HCW Biologics Inc. | -25.71 Million USD | -965.456% |
| XOMA Corporation | -41.84 Million USD | -554.762% |
| Nektar Therapeutics | -137.42 Million USD | -99.385% |
| Arvinas, Inc. | -401.5 Million USD | 31.755% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3098442.016% |
| Merus N.V. | -156.54 Million USD | -75.031% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -173.292% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -691.464% |
| Rezolute, Inc. | -70.42 Million USD | -289.085% |
| Clene Inc. | -40.54 Million USD | -575.888% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1572.958% |
| BeyondSpring Inc. | -23.11 Million USD | -1085.45% |
| Synlogic, Inc. | -55.16 Million USD | -396.737% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1428.278% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2431.458% |
| Peak Bio, Inc. | -1356.23 USD | -20203331.571% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -576.505% |
| Krystal Biotech, Inc. | -109.72 Million USD | -149.715% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -111.522% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 20.118% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -5673.445% |
| MannKind Corporation | 8.67 Million USD | 3257.467% |
| Ikena Oncology, Inc. | -75.41 Million USD | -263.32% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -2740.313% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -307.564% |
| Gossamer Bio, Inc. | -183.75 Million USD | -49.111% |
| CohBar, Inc. | -12.38 Million USD | -2111.805% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -440.188% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -893.24% |
| Legend Biotech Corporation | -439.48 Million USD | 37.653% |
| Mural Oncology plc | -194.63 Million USD | -40.777% |
| Disc Medicine, Inc. | -91.12 Million USD | -200.691% |
| Champions Oncology, Inc. | -7.35 Million USD | -3624.918% |
| REGENXBIO Inc. | -268.12 Million USD | -2.192% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2456.449% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -391.436% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -603.287% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -139.605% |
| Vaxart, Inc. | -83.34 Million USD | -228.752% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -3116.018% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -540.287% |
| Cellectis S.A. | -106.62 Million USD | -156.978% |
| Longeveron Inc. | -21.02 Million USD | -1202.986% |
| Repare Therapeutics Inc. | -116.22 Million USD | -135.756% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -2.308% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -262.225% |
| Revolution Medicines, Inc. | -487.18 Million USD | 43.758% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -4019.137% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -523.39% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -267.348% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -293.487% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -2388.466% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 106.361% |
| Denali Therapeutics Inc. | -196.69 Million USD | -39.302% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3065.249% |
| Veru Inc. | -93.78 Million USD | -192.172% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1074.525% |
| Cingulate Inc. | -22.75 Million USD | -1103.931% |
| Passage Bio, Inc. | -108.38 Million USD | -152.798% |
| Context Therapeutics Inc. | -25.07 Million USD | -992.846% |
| Exicure, Inc. | -14.99 Million USD | -1727.187% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -32.971% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -574.922% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -2719.87% |
| Nuvalent, Inc. | -149.49 Million USD | -83.291% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -3234.81% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -208.804% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1218.98% |
| OmniAb, Inc. | -69.41 Million USD | -294.712% |
| Anew Medical, Inc. | -1.3 Million USD | -20963.697% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2045.525% |
| Lipocine Inc. | -17.93 Million USD | -1428.111% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -299.931% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -259.813% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -619.639% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -593.21% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1124.111% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 52.745% |
| Ocugen, Inc. | -65.53 Million USD | -318.13% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -191.911% |
| Q32 Bio Inc. | -92.1 Million USD | -197.502% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1178.068% |
| Alumis Inc. Common Stock | -158.17 Million USD | -73.23% |
| Equillium, Inc. | -14.52 Million USD | -1786.827% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -339.068% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -3366.948% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1352.443% |
| Dominari Holdings Inc. | -21.79 Million USD | -1157.134% |
| Edesa Biotech, Inc. | -9.22 Million USD | -2870.966% |
| vTv Therapeutics Inc. | -25.5 Million USD | -974.445% |
| Bio-Techne Corporation | 206.68 Million USD | 232.571% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 30.009% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 242.689% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -107.145% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -613.722% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -81.339% |
| Nkarta, Inc. | -131.65 Million USD | -108.131% |
| BioCardia, Inc. | -11.64 Million USD | -2253.186% |
| Iterum Therapeutics plc | -47.46 Million USD | -477.242% |